Apolipoprotein E gene polymorphism in Greek children with nephrotic syndrome by Papadopoulou, Vaia et al.
INTRODUCTION
Nephrotic syndrome (NS) is characterized by severe 
hyperlipidemia, with high cholesterol, triglycerides 
and low-density cholesterol levels1. Lipid abnormali-
ties have been linked to the progression of nephropa-
thy in these patients2, and it has been supported that 
LDL-apheresis or lipid-lowering medications can 
act favourably on nephrotic hypoalbuminemia or al-
buminurea3. Apolipoprotein E (apoE) is a 35-kDa 
plasma protein, which is synthesized in the liver and 
plays essential role in lipid metabolism4. Moreover, it 
contributes in renal protection by regulating mesan-
gial cell proliferation and matrix expansion5. There 
are three major isoforms of apoE, known as apoE2, 
apoE3 and apoE4, products of three alleles (ε2, ε3 
and ε4, respectively) of a single gene on chromosome 
19. Three homozygous phenotypes of apoE (apoE2/2, 
E3/3 and E4/4) and three heterozygous phenotypes 
(apoE2/3, E4/3 and E2/4) can arise from these alleles6. 
It is already well known that apoE genotype variations 
can affect lipoprotein levels7. In specific, E2 homozy-
gous phenotype has been linked to familial dysbetali-
poproteinemia8.
In childhood, NS lipid abnormalities are mostly 
characterized by hypercholesterolemia and, less fre-
quently, by hypertriglyceridemia. Studies have shown 
that apoE polymorphism is associated with renal dis-
ease9 and has been considered a possible prognostic 
factor for the course of childhood NS10. In the present 
study, frequencies of apoE genotypes and alleles in 
Greek children with NS have been evaluated and cor-
related to the degree of their hyperlipidemia, as long 
as no such study has been made yet.
MATERIAL AND METHODS
Forty six children (mean age 6.26±3.2 years) were in-
cluded in the study, either admitted in our department 
or examined in the Outpatient Clinic of our hospital. 
All laboratory assays were performed in the Labora-
tory for Lipids and Cardiovascular Disease Preven-
tion from Childhood of the 2nd Pediatric Department. 
The children were divided into two groups: the study 
group, which consisted of 15 children with diagnosed 
NS and no hypertension or diseases such as hepatitis 
B or C, and the control group, of 31 age-matched chil-
dren with no NS or other chronic disease. Diagnosis 
of NS was made according to the ISKDC criteria11. In 
the study group, only one child had new onset of NS, 
whereas 11 had episodes of relapse and 3 had a history 
of NS in the last five years. Written informed consent 
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to participation in the study was obtained from all pa-
tients and controls. 
Blood samples were collected after overnight 
fast. Serum was separated and stored at -20°C. Total 
cholesterol and triglycerides serum levels were de-
termined using a biochemical analyzer (Hitachi 911, 
Roche Diagnostics GmbH, D-68298 Mannheim). Ge-
nomic DNA from whole blood was obtained by the 
use of a kit (QIAamp Blood DNA purification kit, 
Qiagen, USA). The apoE gene polymorphisms were 
detected by typical polymerase chain reaction (PCR) 
and subsequent reaction fragment length polymor-
phism (RFLP) techniques12,13, with the use of the fol-
lowing primers (Invitrogen):
5´ - TCCAAGGAGCTGCAGGCGGCGCA - 
3´ (23 bp, Tm 68°C) (Forward) and 
5´ - GCCCCGGCCTGGTACACTGCCA - 3´ (22 
bp, Tm 68°C) (Reverse). 
Thermo cycler PTC200 (MJ Research) was used 
for the purpose of the study. 
Statistical analysis of the results was performed 
using SPSS statistical package (v.13). The χ2-test was 
used to evaluate agreement with Hardy-Weinberg 
equilibrium and differences between the two groups. 
Multiple regression analysis was used in order to in-
vestigate possible relation of apoE genotypes to levels 
of total cholesterol and triglycerides. Statistical sig-
nificance was considered for P value less than 0.05.
RESULTS AND DISCUSSION
The results are summarized in Table 1. Both groups 
were in Hardy-Weinberg equilibrium. In specific, 
among the 15 children of the study group, 3 (20.00%) 
had genotype ε2/3, 10 (66.66%) had ε3/3 and 2 
(13.33%) had ε3/4. Among the 31 children of the 
control group, 28 (90.30%) had ε3/3 and 3 (9.70%) 
had ε3/4. The apoE genotype distribution of the study 
group was not statistically significantly different 
when compared with the healthy controls (P > 0.05), 
although ε3/3 frequency was lower in study than in 
control group. Nevertheless, ε2 seems to be present 
only in children with NS. These results come in ac-
cordance with the results of other studies, in which 
ε3/3 is the predominant genotype in different healthy 
populations all over the world14 as well as in popula-
tions of children with NS10,15.
The study of genotypes and alleles according to 
gender in children with NS showed that girls’ geno-
type (n=4) was ε3/3, whereas between boys (n=11), 
3 of them (27.27%) had ε2/3, 6 (54.55%) had ε3/3 
and 2 (18.18%) had ε3/4. Most likely, in the control 
group all girls (n=17) had ε3/3 and genotype distribu-
tion in boys (n=14) was: 11 (78.60%) with ε3/3 and 
3 (21.40%) with ε3/4. This results lead us to the con-
clusion that ε2 allele can be present in male children 
population with NS and not in healthy male children.
The determination of total cholesterol serum lev-
els in children with NS showed the following results 
(mean ± SD): for ε3/3 genotype values were 356.0 ± 
46.2mg/dL, for ε2/3 421.0 ± 45.2 mg/dL and for ε3/4 
440.0 ± 44.3 mg/dL (mgTC/dL=38.5 x mmol/L), show-
ing increased serum total cholesterol levels in the pres-
ence of ε2 or ε4 allele. In refer to triglycerides serum 
levels in the study group, the results were the follow-
ing: for ε3/3 genotype 260.7 ± 157.0 mg/dL, for ε2/3 
335.5 ± 74.3mg/dL and for ε3/4 245.0 ± 44.2 mg/dL 
(mgTG/dL=87.7 x mmol/L). These lead us to the con-
clusion that the presence of ε4 in children with NS is 
mainly associated with severe hypercholesterolemia, 
as it has been shown before1, rather than hypertriglyc-
eridemia. Multiple regression analysis showed that 
total cholesterol serum levels are borderly significant-
ly correlated (P = 0.058) with apoE polymorphism, 
whereas serum levels of triglycerides didn’t pres-
ent any significant correlation with apoE genotypes 
(P = 0.884). 
The present study has the limitation of the small 
number of children participating. That may be attrib-
uted to the reduced number of incidents of NS in child-
hood, in recent years in our country. Nevertheless, the 
results can lead to some primary conclusions on apoE 
polymorphism in Greek children with NS and on the 
relation between severity of their hyperlipidemia and 
their apoE genotype. This needs to be further inves-
tigated in larger patient groups, in order to improve 
prognosis and management and, consequently, the 
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Genotypes n % n %
ε2/2 0 0.00 0 0.00
ε2/3 3 20.00 0 0.00
ε2/4 0 0.00 0 0.00
ε3/3 10 66.66 28 90.30
ε3/4 2 13.33 3 9.70
ε4/4 0 0.00 0 0.00
Alleles
ε2 3 10.00 0 0.00
ε3 25 83.40 59 95.20
ε4 2 6.60 3 4.80
ΠΕΡΙΛΗΨΗ Προσδιορίσθηκαν οι γονότυποι της απολιποπρωτεΐνης Ε (apoE) σε παιδιά με νεφρωσικό σύνδρομο (ΝΣ) 
(ομάδα ελέγχου, Ν=17) και σε ομάδα μαρτύρων (Ν=31). Στους μάρτυρες επικρατούσε ο ε3/ε3. Στην ομάδα ελέγχου, βρέθη-
κε το ε2 αλλήλιο σε αντίθεση με τους μάρτυρες. Συμπερασματικά, η διερεύνηση του γονότυπου μπορεί να βοηθήσει στην 
πρόγνωση του ΝΣ. 
Λέξεις κλειδιά: ApoE, γονότυπος, Νεφρωσικό σύνδρομο, Παιδιά.
Πολυμορφισμός του γονιδίου της απολιποπρωτεΐνης E σε παιδιά  
με νεφρωσικό σύνδρομο στην Ελλάδα.
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